General information

Name National Heart, Lung, and Blood Institute Cohort Studies
Acronym NHLBI
Last update 01/21/2010

Principal investigators

Philip Wolf (Dr.)
Framingham Heart Study, Boston University
Curt Furberg (Dr.)
CHS, Wake Forest University
Barbara Howard (Dr.)
Strong Heart Study, Medlantic Research Foundation
Herman Taylor (Dr.)
Jackson Heart Study, University of Mississippi Medical Center
Aaron Folsom (Dr.)
ARIC, University of Minnesota
Stephen Hulley (Dr.)
CARDIA, University of California
Teri Manolio (Dr.)


Kevin Purkiser (Dr.)
NHLBI, Building 31, Room 5A52
Bethesda 20892
Phone: 301 592 8573




Cardiovascular disease is the leading cause of morbidity and mortality in the US as in most of the world. Risk factors for development of this and related diseases have been and continue to be identified through NHLBI's major cohort studies, but the relationship of disease risk to genetic variation in populations is only beginning to be understood. These well-phenotyped cohorts also include extensive information on environmental modifiers of genetic risk and hold considerable potential for the identification, replication, and interpretation of disease risk related to genes, environment, and their interactions.


To identify risk factors for development, progression, and outcomes of heart, lung, blood, and sleep disorders on a population basis.

Member organizations

Design of the member studies Cohort


© 2005 Public Population Project in Genomics.
All rights reserved.
Information Usage